A type of brain-targeting nano-formulation and its anti-tumour effect in paediatric brain tumour cells

Xin Tiana Department of Pediatric Hematology and Oncology, Children’s Medical Center of Hunan Provincial People’s Hospital of The First Affiliated Hospital (X.T., Y.Y., K.C., A.Y., C.Z., M.Z., X.H.); and School of Medicine (T.S., S.F., Z.L., W.T., X.T.), Hunan Normal University, Changsha 410081, China;b Department of Hematology and Oncology, Children’s Medical Center, Hunan ProvincialView further author information

Taoxiang Shia Department of Pediatric Hematology and Oncology, Children’s Medical Center of Hunan Provincial People’s Hospital of The First Affiliated Hospital (X.T., Y.Y., K.C., A.Y., C.Z., M.Z., X.H.); and School of Medicine (T.S., S.F., Z.L., W.T., X.T.), Hunan Normal University, Changsha 410081, ChinaView further author information

Shiyang Fua Department of Pediatric Hematology and Oncology, Children’s Medical Center of Hunan Provincial People’s Hospital of The First Affiliated Hospital (X.T., Y.Y., K.C., A.Y., C.Z., M.Z., X.H.); and School of Medicine (T.S., S.F., Z.L., W.T., X.T.), Hunan Normal University, Changsha 410081, ChinaView further author information

Zheda Liua Department of Pediatric Hematology and Oncology, Children’s Medical Center of Hunan Provincial People’s Hospital of The First Affiliated Hospital (X.T., Y.Y., K.C., A.Y., C.Z., M.Z., X.H.); and School of Medicine (T.S., S.F., Z.L., W.T., X.T.), Hunan Normal University, Changsha 410081, ChinaView further author information

Yalan Youa Department of Pediatric Hematology and Oncology, Children’s Medical Center of Hunan Provincial People’s Hospital of The First Affiliated Hospital (X.T., Y.Y., K.C., A.Y., C.Z., M.Z., X.H.); and School of Medicine (T.S., S.F., Z.L., W.T., X.T.), Hunan Normal University, Changsha 410081, China;b Department of Hematology and Oncology, Children’s Medical Center, Hunan ProvincialView further author information

Keke Chena Department of Pediatric Hematology and Oncology, Children’s Medical Center of Hunan Provincial People’s Hospital of The First Affiliated Hospital (X.T., Y.Y., K.C., A.Y., C.Z., M.Z., X.H.); and School of Medicine (T.S., S.F., Z.L., W.T., X.T.), Hunan Normal University, Changsha 410081, China;b Department of Hematology and Oncology, Children’s Medical Center, Hunan ProvincialView further author information

Anqi Yaoa Department of Pediatric Hematology and Oncology, Children’s Medical Center of Hunan Provincial People’s Hospital of The First Affiliated Hospital (X.T., Y.Y., K.C., A.Y., C.Z., M.Z., X.H.); and School of Medicine (T.S., S.F., Z.L., W.T., X.T.), Hunan Normal University, Changsha 410081, China;b Department of Hematology and Oncology, Children’s Medical Center, Hunan ProvincialView further author information

Chengguang Zhua Department of Pediatric Hematology and Oncology, Children’s Medical Center of Hunan Provincial People’s Hospital of The First Affiliated Hospital (X.T., Y.Y., K.C., A.Y., C.Z., M.Z., X.H.); and School of Medicine (T.S., S.F., Z.L., W.T., X.T.), Hunan Normal University, Changsha 410081, China;b Department of Hematology and Oncology, Children’s Medical Center, Hunan ProvincialView further author information

Minhui Zenga Department of Pediatric Hematology and Oncology, Children’s Medical Center of Hunan Provincial People’s Hospital of The First Affiliated Hospital (X.T., Y.Y., K.C., A.Y., C.Z., M.Z., X.H.); and School of Medicine (T.S., S.F., Z.L., W.T., X.T.), Hunan Normal University, Changsha 410081, China;b Department of Hematology and Oncology, Children’s Medical Center, Hunan ProvincialView further author information

Wenfang Tanga Department of Pediatric Hematology and Oncology, Children’s Medical Center of Hunan Provincial People’s Hospital of The First Affiliated Hospital (X.T., Y.Y., K.C., A.Y., C.Z., M.Z., X.H.); and School of Medicine (T.S., S.F., Z.L., W.T., X.T.), Hunan Normal University, Changsha 410081, China;b Department of Hematology and Oncology, Children’s Medical Center, Hunan ProvincialView further author information

Xiaojun Taoa Department of Pediatric Hematology and Oncology, Children’s Medical Center of Hunan Provincial People’s Hospital of The First Affiliated Hospital (X.T., Y.Y., K.C., A.Y., C.Z., M.Z., X.H.); and School of Medicine (T.S., S.F., Z.L., W.T., X.T.), Hunan Normal University, Changsha 410081, ChinaCorrespondence[email protected]
View further author information

Xiangling Hea Department of Pediatric Hematology and Oncology, Children’s Medical Center of Hunan Provincial People’s Hospital of The First Affiliated Hospital (X.T., Y.Y., K.C., A.Y., C.Z., M.Z., X.H.); and School of Medicine (T.S., S.F., Z.L., W.T., X.T.), Hunan Normal University, Changsha 410081, China;b Department of Hematology and Oncology, Children’s Medical Center, Hunan ProvincialCorrespondence[email protected]
View further author information

show all

A type of brain-targeting nano-formulation and its anti-tumour effect in paediatric brain tumour cells

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A type of brain-targeting nano-formulation and its anti-tumour effect in paediatric brain tumour cells

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date